Are clinicians overprescribing gabapentinoids for pain?

August 3, 2017

(HealthDay)—Clinicians may be overprescribing gabapentinoids, in part as a response to the opioid epidemic, according to a perspective piece published in the Aug. 3 issue of the New England Journal of Medicine.

Noting that the U.S. Centers for Disease Control and Prevention guidelines recommend gabapentinoids as first-line agents for neuropathic pain, Christopher W. Goodman, M.D., and Allan S. Brett, M.D., from the University of South Carolina School of Medicine in Columbia, present data on their excessive use.

The researchers note that although gabapentinoids are approved for treatment of postherpetic neuralgia, fibromyalgia, and associated with diabetes or , they are increasingly being used for almost any type of pain. U.S. prescribing data support this, with gabapentin being the 10th most commonly prescribed medication in 2016. The increase is suspected to be due to clinicians lowering their threshold for prescribing gabapentinoids; physicians may be using gabapentinoids as a nonopioid, non-acetaminophen, non-nonsteroidal anti-inflammatory drug option. However, there is no robust evidence for off-label use of gabapentinoids; they can have non-trivial side effects; some patients misuse, abuse, or divert gabapentin and pregabalin; and indiscriminate off-label use of gabapentinoids reinforces the tendency to view through a pharmacologic lens.

"Although gabapentinoids offer an alternative that is potentially safer than opioids (and presumably more effective in selected patients), additional research is needed to more clearly define their role in ," the authors write.

Explore further: Pregabalin benefits not linked to prior gabapentin use

More information: Abstract/Full Text

Related Stories

Pregabalin benefits not linked to prior gabapentin use

September 23, 2016
(HealthDay)—Pregabalin is beneficial for neuropathic pain, regardless of previous gabapentin use, according to research published online Sept. 9 in Pain Practice.

Depressed patients more likely to be prescribed opioids

June 20, 2017
A new study shows that patients with low back pain who were depressed were more likely to be prescribed opioids and receive higher doses. Understanding these prescribing patterns sheds new light on the current opioid epidemic ...

Research findings reveal potential to reverse cancer-related nerve pain

May 5, 2016
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.

Pregabalin significantly improves neuropathic pain

September 9, 2016
(HealthDay)—Pregabalin significantly improves neuropathic pain, irrespective of the time since pain onset, according to a study published online Sept. 2 in Pain Practice.

Investigators examine the relationship between pain and opioid abuse

June 12, 2017
The drug overdose epidemic is largely driven by opioids, which continue to be prescribed for chronic pain despite recommendations to use non-opioids for most cases. A new review published in the British Journal of Pharmacology ...

Opioid epidemic takes toll on those with chronic pain

June 30, 2017
It is not a good time to be a pain patient, says Mark Bailey, D.O., Ph.D., a pain specialist at the University of Alabama at Birmingham. It's not a good time to be a pain doctor, or a pharmacist either, he says. The nation ...

Recommended for you

Doctors prescribe opioids at high rates to those at increased overdose risk

April 24, 2018
The number of first-time prescriptions for opioid drugs has not risen since about 2010, according to UCLA researchers. However, patients taking a class of drug known to increase the risk for overdoses were likelier to receive ...

Study: Ibuprofen, acetaminophen more effective than opioids in treating dental pain

April 17, 2018
Opioids are not among the most effective—or longest lasting—options available for relief from acute dental pain, a new examination of the results from more than 460 published studies has found.

Text messaging tool may help fight opioid epidemic

April 17, 2018
A new automated text messaging service may curb opioid abuse and reduce the likelihood of relapse while also decreasing treatment costs, according to researchers at Washington University School of Medicine and Epharmix, a ...

Marijuana-based drug gets positive review from US agency

April 17, 2018
A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday.

Post-surgical opioids can, paradoxically, lead to chronic pain

April 16, 2018
Giving opioids to animals to quell pain after surgery prolongs pain for more than three weeks and primes specialized immune cells in the spinal cord to be more reactive to pain, according to a new study by the University ...

Animal study suggests common diabetes drug may also help with nicotine withdrawal

April 5, 2018
In a mouse study, a drug that has helped millions of people around the world manage their diabetes might also help people ready to kick their nicotine habits.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.